Advertisement
Research Article| Volume 44, ISSUE 2, P129-131, April 2021

Contact Lens Evidence-Based Academic Reports (CLEAR)

      Keywords

      Since contact lenses were invented in 1887, innovations have included advances in optical design, material, care systems, wear modality, lens size, lens shape and applications. Over 19,000 peer reviewed academic papers on the contact lenses have been published. The Contact Lens Evidence-based Academic Reports (CLEAR) follow the exemplary work of organisations such as the Tear Film and Ocular Surface Society dry eye [
      Introduction to the report of the international Dry Eye WorkShop.
      ], meibomian gland disease [
      • Nichols K.K.
      The international workshop on meibomian gland dysfunction: introduction.
      ], contact lens discomfort [
      • Nichols J.J.
      • Jones L.
      • Nelson J.D.
      • Stapleton F.
      • Sullivan D.A.
      • Willcox M.D.
      • et al.
      The TFOS international workshop on contact lens discomfort: introduction.
      ] and dry eye II [
      • Nelson J.D.
      • Craig J.P.
      • Akpek E.K.
      • Azar D.T.
      • Belmonte C.
      • Bron A.J.
      • et al.
      TFOS DEWS II introduction.
      ] workshops and the International Myopia Institute white papers on myopia control [
      • Wolffsohn J.S.
      • Flitcroft D.I.
      • Gifford K.L.
      • Jong M.
      • Jones L.
      • Klaver C.C.W.
      • et al.
      IMI – myopia control reports overview and introduction.
      ], in collating and appraising the academic literature in an ocular field of interest. CLEAR represent the work of nearly 100 multidisciplinary experts in the field, who set out to critically review, synthesise and summarise the research evidence on contact lenses to date; this serves to inform both clinical practice, manufacturing innovation and future research directions.

      1. The process

      CLEAR was conceived by James Wolffsohn in June 2019 and the British Contact Lens Association (BCLA) executive committee gave their backing in September 2019. Philip Morgan was elected as executive vice-chair and the name for the initiative, report topics and leading experts as chairs (Table 1) were agreed together with Cheryl Donnelly, the then Chief Executive Officer of the BCLA. Sponsors were sought to cover the costs of production and publication, but had no input concerning the scope or content of the reports.
      Table 1CLEAR Reports, their Chairs and their Harmonisers.
      CLEAR ReportChairHarmoniser
      Anatomy and physiology of the anterior eye [
      • Downie L.E.
      • Bandlitz S.
      • Bergmanson J.P.G.
      • Craig J.P.
      • Dutta D.
      • Maldonado-Codina C.
      • et al.
      CLEAR – anatomy and physiology of the anterior eye.
      ]
      Laura DownieJames Wolffsohn
      Contact lenses wettability, cleaning, disinfection and interactions with tears [
      • Willcox M.
      • Keir N.
      • Maseedupally V.
      • Masoudi S.
      • McDermott A.
      • Mobeen R.
      • et al.
      CLEAR – contact lenses wettability, cleaning, disinfection and interactions with tears.
      ]
      Mark WillcoxLyndon Jones
      Effect of contact lens materials and designs on the anatomy and physiology of the eye [
      • Morgan P.
      • Murphy P.J.
      • Gifford K.
      • Gifford P.
      • Golebiowski B.
      • Johnson L.
      • et al.
      CLEAR – effect of contact lens materials and designs on the anatomy and physiology of the eye.
      ]
      Philip MorganMark Willcox
      Contact lens optics [
      • Richdale K.
      • Cox I.
      • Kollbaum P.
      • Bullimore M.A.
      • Bakaraju R.C.
      • Gifford P.
      • et al.
      CLEAR – contact lens optics.
      ]
      Kathryn RichdalePhilip Morgan
      Orthokeratology [
      • Vincent S.J.
      • Cho P.
      • Chan K.Y.
      • Fadel D.
      • Ghorbani-Mojarrad N.
      • González-Meijome J.M.
      • et al.
      CLEAR – orthokeratology.
      ]
      Stephen VincentLyndon Jones
      Scleral lenses [
      • Barnett M.
      • Courey C.
      • Fadel D.
      • Lee K.
      • Michaud L.
      • Montani G.
      • et al.
      CLEAR scleral lenses.
      ]
      Melissa BarnettPhilip Morgan
      Medical use of contact lenses [
      • Jacobs D.S.
      • Carrasquillo K.G.
      • Cottrell P.D.
      • Fernández-Velázquez F.J.
      • Gil-Cazorla R.
      • Jalbert I.
      • et al.
      CLEAR – medical use of contact lenses.
      ]
      Deborah JacobsFiona Stapleton
      Contact lens complications [
      • Stapleton F.
      • Bakkar M.
      • Carnt N.
      • Chalmers R.
      • Kumar A.
      • Marasini S.
      • et al.
      CLEAR – contact lens complications.
      ]
      Fiona StapletonJames Wolffsohn
      Evidence-based contact lens practice [
      • Wolffsohn J.S.
      • Dumbleton K.
      • Huntjens B.
      • Kandel H.
      • Koh S.
      • Kunnen C.M.E.
      • et al.
      CLEAR – evidence based contact lens practice.
      ]
      James WolffsohnFiona Stapleton
      Contact lens technologies of the future [
      • Jones L.
      • Hui A.
      • Phan C.-M.-M.
      • Read M.L.
      • Azar D.
      • Buch J.
      • et al.
      CLEAR – contact lens technologies of the future.
      ]
      Lyndon JonesMark Willcox
      Interested clinicians and scientists were invited to apply to working groups and experts in the field (identified by the BCLA and report chairs) were selected to contribute to one of the reports that best fitted their area of expertise and/or practice. An inclusive approach was adopted, while limiting the number of participants from any one research group or company on any single report to ensure a balanced representation.
      The report committees, led by their chair, developed an outline of the subtopics to be covered in their report in January and February 2020 and these were reviewed in March to minimise gaps and overlap. The chairs allocated the subsections of their report to members of their committee and writing commenced in April; drafts were returned to chairs by the end of May to collate and review. This version was reviewed and edited by all committee members by August 2020. From August to September the refined reports were sent to all CLEAR members for review. Their comments were sent back to chairs for addressing (in a similar fashion, but more extensively than would occur through a typical peer review academic journal process) by November 2020. Simultaneously, a medical illustrator was commissioned to draw the necessary original artwork for the reports. The harmonisers (Table 1) met (virtually due to COVID-19 travel limitations) to agree on the standardisation of terminology, abbreviations, formatting, remaining areas of report overlap and abstract development. The finalised reports were submitted to the BCLA’s journal, Contact Lens and Anterior Eye, in January 2021.
      Evidence-based practice can be defined as the “conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients” [
      • Sackett D.L.
      • Rosenberg W.M.C.
      • Gray J.A.M.
      • Haynes R.B.
      • Richardson W.S.
      Evidence based medicine: what it is and what it isn’t.
      ]. It involves integrating the best available, clinically relevant, scientific research evidence with a clinician’s expertise and an individual patient’s values and environment (see CLEAR Evidence-based Practice Report) [
      • Wolffsohn J.S.
      • Dumbleton K.
      • Huntjens B.
      • Kandel H.
      • Koh S.
      • Kunnen C.M.E.
      • et al.
      CLEAR – evidence based contact lens practice.
      ]. Evaluating scientific research findings and using them to make the best clinical decision for patients is a key aim of all evidence-based practice, including fitting and managing contact lenses. The quality of research evidence generally comes from the study design [
      • Wolffsohn J.S.
      • Dumbleton K.
      • Huntjens B.
      • Kandel H.
      • Koh S.
      • Kunnen C.M.E.
      • et al.
      CLEAR – evidence based contact lens practice.
      ]. Formal risk of bias tools also exist to assist clinicians with appraising the quality of an individual study rather than simply relying on the evidence level [
      • Featherston R.
      • Downie L.E.
      • Vogel A.P.
      • Galvin K.L.
      Decision making biases in the allied health professions: a systematic scoping review.
      ].
      Larger cohort studies are considered more informative than expert opinion, case reports or case series and are generally used for epidemiological studies. For management decisions, randomised controlled trials are considered to provide the highest level of evidence-basis; they limit unconscious bias through masking (ideally of the participants and clinical researchers) as to which treatment participants are provided, and randomise participants to treatment and control (or placebo) options. Systematic reviews collate, appraise and synthesise evidence from multiple papers that fit pre-specified eligibility criteria, to answer a specific research question. Hence they are generally considered a higher level of evidence than individual research papers and are often used to inform professional clinical guidelines, which interpret and contextualise their finding to guide and regulate clinical practice. A number of international, evidence-based reviews that inform elements of contact lens practice have been conducted recently, based on a consensus-building workshop approach [
      • Wolffsohn J.S.
      • Flitcroft D.I.
      • Gifford K.L.
      • Jong M.
      • Jones L.
      • Klaver C.C.W.
      • et al.
      IMI – myopia control reports overview and introduction.
      ,
      • Craig J.P.
      • Nelson J.D.
      • Azar D.T.
      • Belmonte C.
      • Bron A.J.
      • Chauhan S.K.
      • et al.
      TFOS DEWS II report executive summary.
      ,
      • Nichols K.K.
      • Foulks G.N.
      • Bron A.J.
      • Glasgow B.J.
      • Dogru M.
      • Tsubota K.
      • et al.
      The international workshop on meibomian gland dysfunction: executive summary.
      ,
      • Nichols J.J.
      • Willcox M.D.
      • Bron A.J.
      • Belmonte C.
      • Ciolino J.B.
      • Craig J.P.
      • et al.
      The TFOS international workshop on contact lens discomfort: executive summary.
      ].
      Individual studies within a given level of the hierarchy level (such as randomised controlled trials) may differ in their ‘quality’, due to differences in their study design, tests performed, cohort selection and participant numbers. Some contact lens research employs study designs that are not explicitly described in hierarchical models of research quality or common in general medicine; these include cross-over, contralateral and monadic designs which are often used to understand the clinical performance of different lenses and care products [
      • Wolffsohn J.S.
      • Dumbleton K.
      • Huntjens B.
      • Kandel H.
      • Koh S.
      • Kunnen C.M.E.
      • et al.
      CLEAR – evidence based contact lens practice.
      ]. While systems for rating the level of evidence of individual papers or hypotheses have been developed, they are not robust enough to systematically apply [
      • Atkins D.
      • Eccles M.
      • Flottorp S.
      • Guyatt G.H.
      • Henry D.
      • Hill S.
      • et al.
      Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group.
      ], hence the approach taken in CLEAR is to present summaries of the research findings and to critically appraise the evidence on relevant topics.

      2. Approach to terminology

      Inconsistent terminologies have developed within the field of contact lenses that can be confusing to students, clinicians, researchers and other stakeholders. Several anatomical terms, named after individuals, such as Bowman’s and Descemet’s membranes, have been renamed the anterior and posterior limiting lamina by the Federative Committee on Anatomical Terminology (FCAT) [
      • Terminology
      FICoA. Terminologia histologica: international terms for human cytology and histology.
      ] and these have been adopted by CLEAR. Whilst the FCAT also renamed ‘Meibomian glands’ as ‘tarsal glands’, this terminology does not logically follow other terms in the field. Meibomian glands produce meibum, and the term tarsal is only attributed to a single anatomical ‘plate’ that is not the sole location of the glands; lacrimal glands are named after the secretion they produce and not their location. Hence, ‘meibomian’ gland terminology, also used in the dry eye disease literature, has been retained in the CLEAR reports. Likewise, tarsal conjunctiva is a region of the palpebral conjunctiva rather than an appropriate term to describe this tissue on the underside of the eyelids.
      The term rigid gas permeable lenses (RGP) was developed to differentiate the first oxygen-permeable hard/rigid lenses from earlier oxygen impermeable materials, such as poly methyl methacrylate (PMMA). In more recent times, this has been truncated to simply ‘gas permeable’ or ‘GP’ by some authors as ‘rigid’ was felt to suggest to potential patients that these lenses would cause discomfort [
      • Efron N.
      Obituary--rigid contact lenses.
      ]. However, all modern contact lenses (soft or rigid) are ‘gas permeable’ and scleral lenses are also RGPs, yet the term is generally used to describe exclusively corneal lenses. Hence, a poll of CLEAR members was conducted and 62 % were in favour of adopting a change in terminology to ‘corneal lens’, 18 % against (mainly as they felt soft lenses also ‘landed’ on the cornea) and the rest (21 %) were equivocal. Since their ‘rigidity’ is a key feature of the optical and health benefits of these lenses, the term ‘rigid corneal lens’ was adopted throughout CLEAR. Scleral lens terminology has recently been redefined [
      • Michaud L.
      • Lipson M.
      • Kramer E.
      • Walker M.
      The official guide to scleral lens terminology.
      ] and CLEAR has accepted this approach, and thus all rigid lenses that vault the cornea are termed ‘scleral lenses’. While regulatory terminology denoted extended wear as 7 days and 6 nights, and continuous wear as up to 30 days and 29 nights [
      • Riley C.
      • Chalmers R.L.
      Survey of contact lens-wearing habits and attitudes toward methods of refractive correction: 2002 versus 2004.
      ], these definitions overlap and are used interchangeably in the literature. Research suggests that there are no marked clinical differences between these modalities [
      • Bialasiewicz A.A.
      Infection immunology in silicone hydrogel contact lenses for continuous wear--a review.
      ]. Hence the terminology ‘planned’ or ‘sporadic’ ‘overnight wear’ is more appropriate for clinical use and has been adopted in these reports.
      The CLEAR harmonisers carefully considered the use of abbreviations throughout the reports, using the principles articulated in Cochrane reviews [
      • Cochrane
      Cochrane style manual.
      ] that they should be used sparingly and only if they are widely known across the broad readership, are used frequently and enhance readability. Two word abbreviations were only adopted where the abbreviation is used more commonly than the words they represent. It is hoped this general list of terms will assist standardisation in future publications in the field and to support new eye care practitioners. Standard unit and country abbreviations are not articulated in full due to these being commonly accepted terms.
      Tabled 1
      General list of abbreviations for the field of contact lenses-->
      BAKbenzalkonium chloride
      BOZR/BOZDback optic zone radius/diameter
      CIECorneal infiltrative event
      CLDcontact lens discomfort
      CLIDEcontact lens induced dry eye
      CLPCcontact lens-induced papillary conjunctivitis
      Dk/toxygen permeability/transmissibility
      ECPeye care practitioner
      EDOFextended depth of focus
      EDTAethylenediaminetetraacetic Acid
      HEMA2-hydroxyethyl methacrylate
      HPMChydroxypropyl methylcellulose
      HVIDhorizontal visible iris diameter
      LIPCOFlid-parallel conjunctival folds
      LWElid wiper epitheliopathy
      MGDmeibomian gland dysfunction
      MKmicrobial keratitis
      MPDSmultipurpose disinfecting solution
      Ortho-korthokeratology
      PEGpolyethylene glycol
      PHMBpolyhexamethylene biguanide
      PMMApolymethyl methacrylate
      PoLTFpost-lens tear film
      PVApolyvinyl alcohol
      PVPpolyvinyl pyrrolidone
      SICSsolution induced corneal staining
      SiHysilicone-hydrogel soft contact lens
      VPAvertical palpebral aperture

      3. CLEAR

      The collaboration between experts in the field of contact lenses and the anterior eye has been inspiring and productive, despite the enforced ‘virtual’ nature of the interactions due to the COVID-19 pandemic. These reports bring together the evidence, and consensus where this was lacking, to inform clinical practice, identifying areas where further research is needed and determining where there are opportunities for new innovations from industry.

      Acknowledgements

      The CLEAR initiative was facilitated by the BCLA, with financial support by way of Educational Grants for collaboration, publication and dissemination provided by Alcon and CooperVision.

      References

      1. Introduction to the report of the international Dry Eye WorkShop.
        Ocular Sci. 2007; 5: 69-70
        • Nichols K.K.
        The international workshop on meibomian gland dysfunction: introduction.
        Invest Ophthalmol Vis Sci. 2011; 52: 1917-1921
        • Nichols J.J.
        • Jones L.
        • Nelson J.D.
        • Stapleton F.
        • Sullivan D.A.
        • Willcox M.D.
        • et al.
        The TFOS international workshop on contact lens discomfort: introduction.
        Invest Ophthalmol Vis Sci. 2013; 54: TFOS1-TFOS6
        • Nelson J.D.
        • Craig J.P.
        • Akpek E.K.
        • Azar D.T.
        • Belmonte C.
        • Bron A.J.
        • et al.
        TFOS DEWS II introduction.
        Ocul Surf. 2017; 15: 269-275
        • Wolffsohn J.S.
        • Flitcroft D.I.
        • Gifford K.L.
        • Jong M.
        • Jones L.
        • Klaver C.C.W.
        • et al.
        IMI – myopia control reports overview and introduction.
        Invest Ophthalmol Vis Sci. 2019; 60: M1-M19
        • Downie L.E.
        • Bandlitz S.
        • Bergmanson J.P.G.
        • Craig J.P.
        • Dutta D.
        • Maldonado-Codina C.
        • et al.
        CLEAR – anatomy and physiology of the anterior eye.
        Contact Lens Anterior Eye. 2021; 44: 132-156
        • Willcox M.
        • Keir N.
        • Maseedupally V.
        • Masoudi S.
        • McDermott A.
        • Mobeen R.
        • et al.
        CLEAR – contact lenses wettability, cleaning, disinfection and interactions with tears.
        Contact Lens Anterior Eye. 2021; 44: 157-191
        • Morgan P.
        • Murphy P.J.
        • Gifford K.
        • Gifford P.
        • Golebiowski B.
        • Johnson L.
        • et al.
        CLEAR – effect of contact lens materials and designs on the anatomy and physiology of the eye.
        Contact Lens Anterior Eye. 2021; 44: 192-219
        • Richdale K.
        • Cox I.
        • Kollbaum P.
        • Bullimore M.A.
        • Bakaraju R.C.
        • Gifford P.
        • et al.
        CLEAR – contact lens optics.
        Contact Lens Anterior Eye. 2021; 44: 220-239
        • Vincent S.J.
        • Cho P.
        • Chan K.Y.
        • Fadel D.
        • Ghorbani-Mojarrad N.
        • González-Meijome J.M.
        • et al.
        CLEAR – orthokeratology.
        Contact Lens Anterior Eye. 2021; 44: 240-269
        • Barnett M.
        • Courey C.
        • Fadel D.
        • Lee K.
        • Michaud L.
        • Montani G.
        • et al.
        CLEAR scleral lenses.
        Contact Lens Anterior Eye. 2021; 44: 270-288
        • Jacobs D.S.
        • Carrasquillo K.G.
        • Cottrell P.D.
        • Fernández-Velázquez F.J.
        • Gil-Cazorla R.
        • Jalbert I.
        • et al.
        CLEAR – medical use of contact lenses.
        Contact Lens Anterior Eye. 2021; 44: 289-329
        • Stapleton F.
        • Bakkar M.
        • Carnt N.
        • Chalmers R.
        • Kumar A.
        • Marasini S.
        • et al.
        CLEAR – contact lens complications.
        Contact Lens Anterior Eye. 2021; 44: 330-367
        • Wolffsohn J.S.
        • Dumbleton K.
        • Huntjens B.
        • Kandel H.
        • Koh S.
        • Kunnen C.M.E.
        • et al.
        CLEAR – evidence based contact lens practice.
        Contact Lens Anterior Eye. 2021; 44: 368-397
        • Jones L.
        • Hui A.
        • Phan C.-M.-M.
        • Read M.L.
        • Azar D.
        • Buch J.
        • et al.
        CLEAR – contact lens technologies of the future.
        Contact Lens Anterior Eye. 2021; 44: 398-430
        • Sackett D.L.
        • Rosenberg W.M.C.
        • Gray J.A.M.
        • Haynes R.B.
        • Richardson W.S.
        Evidence based medicine: what it is and what it isn’t.
        Br Med J. 1996; 312: 71-72
        • Featherston R.
        • Downie L.E.
        • Vogel A.P.
        • Galvin K.L.
        Decision making biases in the allied health professions: a systematic scoping review.
        PLoS One. 2020; 15e0240716
        • Craig J.P.
        • Nelson J.D.
        • Azar D.T.
        • Belmonte C.
        • Bron A.J.
        • Chauhan S.K.
        • et al.
        TFOS DEWS II report executive summary.
        Ocul Surf. 2017; 15: 802-812
        • Nichols K.K.
        • Foulks G.N.
        • Bron A.J.
        • Glasgow B.J.
        • Dogru M.
        • Tsubota K.
        • et al.
        The international workshop on meibomian gland dysfunction: executive summary.
        Invest Ophthalmol Vis Sci. 2011; 52: 1922-1929
        • Nichols J.J.
        • Willcox M.D.
        • Bron A.J.
        • Belmonte C.
        • Ciolino J.B.
        • Craig J.P.
        • et al.
        The TFOS international workshop on contact lens discomfort: executive summary.
        Invest Ophthalmol Vis Sci. 2013; 54: 7-13
        • Atkins D.
        • Eccles M.
        • Flottorp S.
        • Guyatt G.H.
        • Henry D.
        • Hill S.
        • et al.
        Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group.
        BMC Health Serv Res. 2004; 4: 38
        • Terminology
        FICoA. Terminologia histologica: international terms for human cytology and histology.
        2008
        • Efron N.
        Obituary--rigid contact lenses.
        Cont Lens Anterior Eye. 2010; 33: 245-252
        • Michaud L.
        • Lipson M.
        • Kramer E.
        • Walker M.
        The official guide to scleral lens terminology.
        Cont Lens Anterior Eye. 2020; 43: 529-534
        • Riley C.
        • Chalmers R.L.
        Survey of contact lens-wearing habits and attitudes toward methods of refractive correction: 2002 versus 2004.
        Optom Vis Sci. 2005; 82: 555-561
        • Bialasiewicz A.A.
        Infection immunology in silicone hydrogel contact lenses for continuous wear--a review.
        Klin Monbl Augenheilkd. 2003; 220: 453-458
        • Cochrane
        Cochrane style manual.
        2020